Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs MultiMedRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MultiMedRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 504 · Grade C

MultiMedRx

Visit MultiMedRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 50 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make MultiMedRx a bad call — it's best for readers who can confirm separate care and medication charges. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
40
Supply Reliability
95
74
Transparency
90
20
Access Breadth
93
36
Clinical Oversight
92
72
Track Record
88
70
CoreAge RxBrief Score 94 · 50MultiMedRx

Price, coverage & the tracker

CoreAge RxMultiMedRx
Brief Score94/100 (A)50/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$139 intro offer for four weeks; $199 regular price advertised.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$179 intro offer for four weeks; $299 regular price advertised.

CoverageUS only; restrictions by state, confirmed at intakeConfirm clinician and pharmacy availability in your state.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

MultiMedRx: Confirm whether the care and treatment charges use different intervals.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.